44.211.24.81
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Oculoplastics

Teprotumumab significantly reduces extraocular muscle cross-sectional area in TED

After treatment with teprotumumab in patients with thyroid eye disease (TED), extraocular muscle (EOM) cross-sectional areas (CSA) is significantly reduced, according to a study. In this retrospective study, pre- and post-teprotumumab treatment CT imaging of 48 orbits of 24 patients with thyroid eye disease were evaluated by 2 radiographic reviewers...

Read More
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-